Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gephyrin pseudogene (ENSG00000271697) is a nonfunctional DNA sequence in the human genome with high similarity to the *gephyrin* gene (GPHN), but it does not encode a functional gephyrin protein or any other known protein product[1][4]. Pseudogenes are typically remnants of genes that have lost their ability to code for proteins due to disabling mutations, such as frameshifts or premature stop codons, and are considered a type of "junk DNA," although some pseudogenes have been shown to play regulatory roles as RNA in rare cases[1][3]. No evidence suggests that this gephyrin pseudogene has any physiological, disease, or therapeutic relevance[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gephyrin pseudogene.